Clinical Trials
9 trialsNCT04918186 2026-05-12
IPROC
Canadian Cancer Trials Group
Phase 2 Recruiting
NCT07363330 2026-01-26
A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer
Zhongnan Hospital
Phase 2 Not yet recruiting
NCT06416696 2026-01-02
Toripalimab for High-risk Locally Advanced Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT07092696 2025-07-30
Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy for Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06020755 2024-12-31
TA7
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT06548763 2024-08-12
Oral Topotecan With Toripalimab for Patients With Endometrial Cancer
Fudan University
Phase 2 Not yet recruiting
NCT05342506 2022-04-22
Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04973904 2021-07-22
Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04395612 2021-05-21
CQGOG0101
Chongqing University Cancer Hospital
Phase 2 Unknown